ORPHA:324569
Pontocerebellar hypoplasia type 8
Also known as: PCH8 · Pontocerebellar hypoplasia due to CHMP1A mutation
Publications
671
Trials
0
Interventional, condition-specific
Researchers
145
Distinct authors in sample
Gene link
CHMP1A
Strong
Readiness
5/6
Stages with a signal
Clinical definition (Orphanet)
Pontocerebellar hypoplasia type 8 (PCH8) is a novel very rare form of pontocerebellar hypoplasia characterized clinically by microencephaly, feeding difficulties, severe , although walking may be achieved, often associated with increased muscle tone of lower extremities and deep tendon reflexes, joint deformities in the lower extremities, and occasionally complex . PCH8 is caused by a loss-of-function mutation in the CHMP1A gene. MRI demonstrates a pontocerebellar hypoplasia with vermis and hemispheres equally affected and mild to severely reduced cerebral white matter volume with a fully formed very thin corpus callosum.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0013990
- OMIM:614961
- UMLS:C3554209
Additional Mondo synonyms (4)
CHMP1A non-syndromic pontocerebellar hypoplasia · non-syndromic pontocerebellar hypoplasia caused by mutation in CHMP1A · pontocerebellar hypoplasia due to CHMP1A mutation · pontocerebellar hypoplasia type 8
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
5/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedPresent
Strong — CHMP1A
- LiteraturePresent
671 matched papers (489 in last 10 years) Source
- Phenotype characterisedPresent
48 HPO annotations (e.g. Tented upper lip vermilion; Talipes valgus; Intellectual disability) Source
- Animal modelPresent
1 genotype model (Danio rerio) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 1 for broader category pontocerebellar hypoplasia
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (CHMP1A).
GenCC classification: Strong.
Phenotypes (Monarch / HPO)
48
Associated phenotypes · MONDO:0013990
- Tented upper lip vermilion
- Talipes valgus
- Intellectual disability
- Long eyelashes
- Esotropia
Showing 5 of 48 — open Monarch for the full list.
Animal models (Monarch / Alliance)
1
Model associations linked to this Mondo ID
- chmp1azf4111/+·ZFIN:ZDB-FISH-250611-24·Danio rerio
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
671
671 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
671 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
489 in the last 10 years · low confidence
Phrase hits: 10 · MeSH hits: 0
Who's working on it?
145
Distinct author names in 10 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Li L3 papers · 2023
BGI-Wuhan Clinical Laboratory, BGI-Shenzhen, 430074, Wuhan, China.
Papers in Europe PMC - 02Fujita A2 papers · 2023
Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Papers in Europe PMC - 03Hamanaka K2 papers · 2023
Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Papers in Europe PMC - 04Koshimizu E2 papers · 2023
Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Papers in Europe PMC - 05Liu Y2 papers · 2023
Department of Genetics, Jiangxi Maternal and Child Health Hospital, 330006, Nanchang, China.
Papers in Europe PMC - 06Matsui S2 papers · 2023
Department of Pediatrics, Tokyo Children Rehabilitation Hospital, Tokyo, Japan.
Papers in Europe PMC - 07Matsumoto N2 papers · 2023
Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan. naomat@yokohama-cu.ac.jp.
Papers in Europe PMC - 08Misawa K2 papers · 2023
Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Papers in Europe PMC - 09Miyatake S2 papers · 2023
Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Papers in Europe PMC - 10Mizuguchi T2 papers · 2023
Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 1 trial are registered for pontocerebellar hypoplasia, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
1 interventional trial matched pontocerebellar hypoplasia, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: pontocerebellar hypoplasia
1
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Pontocerebellar hypoplasia type 8 — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Pontocerebellar hypoplasia type 8" OR "Pontocerebellar hypoplasia due to CHMP1A mutation" OR "CHMP1A non-syndromic pontocerebellar hypoplasia" OR "non-syndromic pontocerebellar hypoplasia caused by mutation in CHMP1A") OR ("CHMP1A" OR "CHMP1A syndrome" OR "CHMP1A-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Pontocerebellar hypoplasia type 8" OR "Pontocerebellar hypoplasia due to CHMP1A mutation" OR "CHMP1A non-syndromic pontocerebellar hypoplasia" OR "non-syndromic pontocerebellar hypoplasia caused by mutation in CHMP1A"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"pontocerebellar hypoplasia"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: PCH8
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (671) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-27T13:37:44.706Z
